Literature DB >> 3574431

Aspergillus myositis in a patient with a myelodysplastic syndrome.

A C Reboli, R F Reilly, R J Jacobson.   

Abstract

We present the case of an elderly man who, while being treated with corticosteroids for a myelodysplastic syndrome, developed myositis of the calf due to Aspergillus fumigatus. Despite therapy with amphotericin B the myositis failed to resolve and he died. At autopsy, a localized necrotizing myositis of the right calf was found with no evidence of disseminated Aspergillus infection. Myositis in the setting of disseminated candidiasis or cryptococcosis has been previously reported. This case is unique in that it is the first reported case of localized fungal myositis and of myositis caused by Aspergillus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3574431     DOI: 10.1007/bf00436849

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  13 in total

1.  Microsporidiosis myositis in a patient with the acquired immunodeficiency syndrome.

Authors:  D K Ledford; M D Overman; A Gonzalvo; A Cali; S W Mester; R F Lockey
Journal:  Ann Intern Med       Date:  1985-05       Impact factor: 25.391

2.  Disseminated cryptococcosis with muscular involvement.

Authors:  V E Jiménez-Lucho; R Del Busto; E J Fisher
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

3.  Fever, rash, and myalgias of dissseminated candidiasis during antifungal therapy.

Authors:  F P Arena; M Perlin; H Brahman; B Weiser; D Armstrong
Journal:  Arch Intern Med       Date:  1981-08

4.  Pyomyositis. Increasing recognition in temperate climates.

Authors:  R K Gibson; S J Rosenthal; B P Lukert
Journal:  Am J Med       Date:  1984-10       Impact factor: 4.965

5.  Therapy of murine aspergillosis with amphotericin B in combination with rifampin of 5-fluorocytosine.

Authors:  J Arroyo; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

6.  Activity of amphotericin B, 5-fluorocytosine, and rifampin against six clinical isolates of Aspergillus.

Authors:  M Kitahara; V K Seth; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

7.  Concomitant pulmonary aspergillosis and nocardiosis in a patient with chronic granulomatous disease of childhood.

Authors:  T B Casale; A M Macher; A S Fauci
Journal:  South Med J       Date:  1984-02       Impact factor: 0.954

8.  Pyomyositis. Review of 205 cases in 112 patients.

Authors:  L C Chiedozi
Journal:  Am J Surg       Date:  1979-02       Impact factor: 2.565

9.  Pyomyositis: tropical disease in a temperate climate.

Authors:  W F Schlech; P Moulton; A B Kaiser
Journal:  Am J Med       Date:  1981-11       Impact factor: 4.965

10.  Fever, rash, and muscle tenderness. A distinctive clinical presentation of disseminated candidiasis.

Authors:  C I Jarowski; M A Fialk; H W Murray; G J Gottlieb; M Coleman; C R Steinberg; R T Silver
Journal:  Arch Intern Med       Date:  1978-04
View more
  3 in total

Review 1.  Bacterial, fungal, parasitic, and viral myositis.

Authors:  Nancy F Crum-Cianflone
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

2.  Nonbacterial myositis.

Authors:  Nancy F Crum-Cianflone
Journal:  Curr Infect Dis Rep       Date:  2010-09       Impact factor: 3.725

3.  Treatment of fungal myositis with intra-lesional and intravenous itraconazole: a case report.

Authors:  Xiao-Ji Lin; Rong-Xin Yao; Mu-Qing He; Bao-Ling Zhu; Wen-Jian Guo
Journal:  J Med Case Rep       Date:  2013-05-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.